BEAM THERAPEUTIC (BEAM)

Thanks to one small protein sequencing startup, we're entering a new era of proteomics via NGPS technologies that will enable massively parallel protein sequencing.

Forget About the Genomic Revolution, the Proteomic Revolution Is Coming

By Luke Lango, InvestorPlace Senior Investment Analyst Sep 3, 2021

Thanks to one small protein sequencing startup, we're entering a new era of proteomics via NGPS technologies that will enable massively parallel protein sequencing.

Investing in CRISPR Stocks: Ultimate Genetic Editing Guide

By Luke Lango, InvestorPlace Senior Investment Analyst Jul 5, 2021

The biotech space is on the verge of hypergrowth, thanks to a scientific breakthrough in genetic editing. This is your ultimate guide to understanding and profiting from CRISPR stocks.

The Top 7 Gene-Editing Stocks to Buy for the Biggest Scientific Breakthrough of the Century

By Luke Lango, InvestorPlace Senior Investment Analyst Jul 1, 2021

Doudna's breakthrough in CRISPR has since ushered in a new era of genetic engineering, making these the best gene-editing stocks to buy.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Jun 28, 2021

Good morning! Let's get ready for trading to start off strong this week with a look at the biggest pre-market stock movers for Monday!

Gene Editing Stocks: What BLUE, NTLA, BEAM, CRSP and EDIT Are Doing Today

By William White, InvestorPlace Writer Mar 10, 2021

Gene editing stocks are on the move Wednesday with investors taking extra interest in biotech companies on news from two major players.

This Unique Gene Editing Stock Could Turn into the Genomic Revolution’s Biggest Winner

By Luke Lango, InvestorPlace Senior Investment Analyst Feb 5, 2021

Beam Therapeutics (BEAM) is pioneering a new evolution of gene editing techniques that could be the key to making safer genomic medicines.

7 CRISPR Stocks for the Future of Medicine

By Luke Lango, InvestorPlace Senior Investment Analyst Jan 15, 2021

Between these seven genetic editing pioneers, you have the widest exposure to the biggest scientific breakthrough of the century.

UA, BEAM: Under Armour to Replace Beam in S&P 500

By Christopher Freeburn, InvestorPlace Writer Apr 25, 2014

Under Armour will join the S&P 500 on April 30, replacing Beam, which is being acquired by Suntory. UA stock rose on the news.

Diageo Stock Keeps Pouring Dividends for Investors

By Mar 21, 2014

Diageo plc produces, distills, brews, bottles, packages, and distributes spirits. Diageo stock is a good value right now, and a solid dividend stock to own

Dip Into Brown-Forman Stock for Dividend Growth

By Feb 14, 2014

Brown-Forman engages in all facets of the alcoholic beverages process. Brown-Forman stock will provide dividend investors with income for the long haul

5 Quality Dividend Stocks I Bought on the Dip

By Feb 11, 2014

In the past couple of weeks, I've taken advantage of the weak market by adding to my positions in 5 dividend stocks. Here is the list of those 5 dividend stocks

Concerned About a Selloff? Here’s 68 Things You Can Do

By Louis Navellier, Editor, Growth Investor Jan 28, 2014

Last week's market drop caused concern among investors; there is no need to panic, and I'll start you off with stocks to buy on the pullback

BEAM – Japan’s Suntory to Buy Jim Beam Parent in $16B Deal

By Christopher Freeburn, InvestorPlace Writer Jan 13, 2014

Japan's Suntory says it will pay $16 billion to acquire Illinois-based Beam Inc., a 25% premium over BEAM's last closing price.

End 2013 on a High Note With These 58 Stock Trades

By Louis Navellier, Editor, Growth Investor Dec 10, 2013

Heading into the end of the year means looking through opportunities to make both buy and sell stock trades. Here are 58 updated rankings to get started